CAS 175140-00-8

4-Pyridinamine,N-(1-ethylpropyl)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)-

Description:

4-Pyridinamine, N-(1-ethylpropyl)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)-, with the CAS number 175140-00-8, is an organic compound characterized by its pyridine ring structure, which is a six-membered aromatic heterocycle containing one nitrogen atom. This compound features multiple substituents, including an ethylpropyl group and a trimethylphenoxy moiety, contributing to its complexity and potential biological activity. The presence of methyl groups on the pyridine ring enhances its lipophilicity, which may influence its solubility and interaction with biological membranes. The compound's structure suggests potential applications in pharmaceuticals or agrochemicals, as derivatives of pyridine often exhibit diverse biological properties. Additionally, the specific arrangement of substituents can affect the compound's reactivity and stability. As with many organic compounds, its physical properties, such as melting point, boiling point, and solubility, would need to be determined experimentally or sourced from literature for practical applications. Overall, this compound represents a unique structure within the realm of pyridine derivatives.

Formula: C₂₁H₃₀N₂O

4-Pyridinamine, N-(1-ethylpropyl)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)-

CAS: 175140-00-8

Formula: C₂₁H₃₀N₂O

Purity: 98%

Molecular weight: 326.4757

Ref: IN-DA0020C4

CP 376395

CAS: 175140-00-8

CP 376395

Purity: ≥98%

Molecular weight: 326.48g/mol

Ref: 54-BUP09632

CP 376395

CAS: 175140-00-8

CP 376395 (CP-316311) is an effective and specific Corticotropin-releasing factor 1 (CRF1) receptor antagonist.

Formula: C₂₁H₃₀N₂O

Purity: 99.86% - 99.94%

Color and Shape: Solid

Molecular weight: 326.48

Ref: TM-T4329

CP 376395

CAS: 175140-00-8

CP 376395 is a drug that acts as a glucocorticoid receptor agonist. It has been shown to have an effective dose of 5mg/kg in the rat model and 10mg/kg in the mouse model. CP 376395 has been shown to be a potential drug target for congestive heart failure, which may be due to its ability to modulate neurotransmission through activation of dopamine receptors. CP 376395 has been shown to bind with high affinity to glucocorticoid receptors, which are present in many tissues and play important roles in metabolism. The binding of CP 376395 can lead to changes in the expression of genes that regulate the synthesis or metabolism of proteins or peptides such as hormones, enzymes, or other signaling molecules (e.g., cytokines).

Formula: C₂₁H₃₀N₂O

Purity: Min. 95%

Molecular weight: 326.48 g/mol

Ref: 3D-AHA14000